{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:04:09Z","timestamp":1768194249536,"version":"3.49.0"},"reference-count":126,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:00:00Z","timestamp":1703980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Fibrotic pulmonary sarcoidosis represents a distinct and relatively uncommon manifestation within the spectrum of sarcoidosis and has substantial morbidity and mortality. Due to the scarcity of research focused on this specific disease subtype, our current understanding of pathogenesis and optimal management remains constrained. This knowledge gap underscores the need for further investigation into areas such as targeted therapies, lung transplantation, and quality of life of patients with fibrotic pulmonary sarcoidosis. The primary aim of this review is to discuss recent developments within the realm of fibrotic pulmonary sarcoidosis to foster a more comprehensive understanding of the underlying mechanisms, prognosis, and potential treatment modalities.<\/jats:p>","DOI":"10.3390\/jcm13010241","type":"journal-article","created":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T06:00:21Z","timestamp":1704002421000},"page":"241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Manifestations and Management of Fibrotic Pulmonary Sarcoidosis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6424-849X","authenticated-orcid":false,"given":"Jin Sun","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, PA 19140, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8764-6538","authenticated-orcid":false,"given":"Rohit","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University Hospital, Philadelphia, PA 19140, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,31]]},"reference":[{"key":"ref_1","first-page":"149","article-title":"Ats\/ers\/wasog statement on sarcoidosis. American thoracic society\/european respiratory society\/world association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.123.2.406","article-title":"The diagnostic pathway to sarcoidosis","volume":"123","author":"Judson","year":"2003","journal-title":"Chest"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official american thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","article-title":"Sarcoidosis","volume":"361","author":"Baughman","year":"2003","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"537382","DOI":"10.3389\/fimmu.2020.537382","article-title":"Sarcoidosis epidemiology: Race matters","volume":"11","author":"Hena","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the united states","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in england. A review of 136 cases after five years\u2019 observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br. Med. J."},{"key":"ref_8","first-page":"119","article-title":"The clinical course of sarcoidosis: Presentation, diagnosis, and treatment in a large white and black cohort in the united states","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_9","first-page":"147","article-title":"Pulmonary and psychosocial findings at enrollment in the access study","volume":"22","author":"Yeager","year":"2005","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1164\/rccm.202106-1366CI","article-title":"Management of advanced pulmonary sarcoidosis","volume":"205","author":"Gupta","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-0040-1709495","article-title":"Advanced pulmonary sarcoidosis","volume":"41","author":"Gupta","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage iv sarcoidosis: Comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105997","DOI":"10.1016\/j.rmed.2020.105997","article-title":"Predictors of mortality in fibrosing pulmonary sarcoidosis","volume":"169","author":"Jeny","year":"2020","journal-title":"Respir. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1901747","DOI":"10.1183\/13993003.01747-2019","article-title":"Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: Results from an international registry","volume":"55","author":"Shlobin","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.122.1.233","article-title":"Outcomes for patients with sarcoidosis awaiting lung transplantation","volume":"122","author":"Shorr","year":"2002","journal-title":"Chest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-021-01818-5","article-title":"Associations between occupational and environmental exposures and organ involvement in sarcoidosis: A retrospective case-case analysis","volume":"22","author":"Ronsmans","year":"2021","journal-title":"Respir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/MCP.0000000000000796","article-title":"The emerging role of inorganic elements as potential antigens in sarcoidosis","volume":"27","author":"Beijer","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12931-020-01409-w","article-title":"Immunoreactivity to metal and silica associates with sarcoidosis in dutch patients","volume":"21","author":"Beijer","year":"2020","journal-title":"Respir. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1164\/rccm.200209-1097OC","article-title":"Sarcoidosis susceptibility and resistance hla-dqb1 alleles in african americans","volume":"167","author":"Iannuzzi","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.gene.6364235","article-title":"Genome-wide search for sarcoidosis susceptibility genes in african americans","volume":"6","author":"Iannuzzi","year":"2005","journal-title":"Genes Immun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00439-006-0201-6","article-title":"Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in african americans on chromosome 5","volume":"120","author":"Sinha","year":"2006","journal-title":"Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"Hla-drb1*1101: A significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/gene.2012.48","article-title":"Association of anxa11 genetic variation with sarcoidosis in african americans and european americans","volume":"14","author":"Levin","year":"2013","journal-title":"Genes Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1210\/en.2004-0766","article-title":"Skeletal overexpression of gremlin impairs bone formation and causes osteopenia","volume":"146","author":"Gazzerro","year":"2005","journal-title":"Endocrinology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1183\/09031936.98.12040913","article-title":"Transforming growth factor-beta1 in sarcoidosis","volume":"12","author":"Salez","year":"1998","journal-title":"Eur. Respir. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1399-0039.2010.01590.x","article-title":"Genetic variation in grem1 is a risk factor for fibrosis in pulmonary sarcoidosis","volume":"77","author":"Heron","year":"2011","journal-title":"Tissue Antigens"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1378\/chest.129.6.1584","article-title":"Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis","volume":"129","author":"Kruit","year":"2006","journal-title":"Chest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1183\/09031936.00010209","article-title":"Card15\/nod2 polymorphisms are associated with severe pulmonary sarcoidosis","volume":"35","author":"Sato","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1164\/rccm.200512-1839OC","article-title":"Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis","volume":"174","author":"Hill","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/17476348.2023.2183193","article-title":"An expert overview of pulmonary fibrosis in sarcoidosis","volume":"17","author":"Gupta","year":"2023","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2003468","DOI":"10.1183\/13993003.03468-2020","article-title":"Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome","volume":"58","author":"Lepzien","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"220178","DOI":"10.1183\/16000617.0178-2022","article-title":"Immune mechanisms in fibrotic pulmonary sarcoidosis","volume":"31","author":"Weeratunga","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1164\/rccm.201304-0760OC","article-title":"The toll-like receptor 3 l412f polymorphism and disease progression in idiopathic pulmonary fibrosis","volume":"188","author":"Armstrong","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200808-1201OC","article-title":"Serum cc-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis","volume":"179","author":"Prasse","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clim.2010.06.017","article-title":"Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction","volume":"137","author":"Pechkovsky","year":"2010","journal-title":"Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human th17 cells selectively express p-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"Ramesh","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1701124","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased t-helper 17.1 cells in sarcoidosis mediastinal lymph nodes","volume":"51","author":"Broos","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2015.08.061","article-title":"An il-23r\/il-22 circuit regulates epithelial serum amyloid a to promote local effector th17 responses","volume":"163","author":"Sano","year":"2015","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.bjc.6605700","article-title":"Serum amyloid a is elevated in the serum of lung cancer patients with poor prognosis","volume":"102","author":"Cho","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Beijer, E., Roodenburg-Benschop, C., Schimmelpennink, M.C., Grutters, J.C., Meek, B., and Veltkamp, M. (2021). Elevated serum amyloid a levels are not specific for sarcoidosis but associate with a fibrotic pulmonary phenotype. Cells, 10.","DOI":"10.3390\/cells10030585"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory t cells: Mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory t cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.1202891","article-title":"Reversal of global cd4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis","volume":"190","author":"Richmond","year":"2013","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/cei.12715","article-title":"Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (icos) expression on lung regulatory t cells\u2014Possible implications for the icos\/icos-ligand axis in disease course and resolution","volume":"183","author":"Sakthivel","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1185443","DOI":"10.3389\/fimmu.2023.1185443","article-title":"Imbalanced distribution of regulatory t cells and th17.1 cells in the peripheral blood and balf of sarcoidosis patients: Relationship to disease activity and the fibrotic radiographic phenotype","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"Mtor signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.it.2020.01.007","article-title":"Sarcoidosis and the mtor, rac1, and autophagy triad","volume":"41","author":"Pacheco","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2002950","DOI":"10.1183\/13993003.02950-2020","article-title":"Transcriptomics of bronchoalveolar lavage cells identifies new molecular endotypes of sarcoidosis","volume":"58","author":"Vukmirovic","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mtorc1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"719009","DOI":"10.3389\/fimmu.2021.719009","article-title":"Hypoxia promotes a mixed inflammatory-fibrotic macrophages phenotype in active sarcoidosis","volume":"12","author":"Jeny","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_54","unstructured":"Lofgren, R., Meholic, A., and Ketai, L. (1996). Fundamentals of Chest Radiology, WB Saunders."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2214\/ajr.174.6.1741751","article-title":"Sarcoidosis with pulmonary fibrosis: Ct patterns and correlation with pulmonary function","volume":"174","author":"Abehsera","year":"2000","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/thx.45.4.272","article-title":"Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction","volume":"45","author":"Udwadia","year":"1990","journal-title":"Thorax"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1148\/rg.306105512","article-title":"Pulmonary sarcoidosis: Typical and atypical manifestations at high-resolution ct with pathologic correlation","volume":"30","author":"Criado","year":"2010","journal-title":"Radiographics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: A case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.semnuclmed.2022.08.004","article-title":"Fdg pet\/ct imaging of sarcoidosis","volume":"53","author":"Regis","year":"2023","journal-title":"Semin. Nucl. Med."},{"key":"ref_60","first-page":"66","article-title":"Imaging the inflammatory activity of sarcoidosis: Sensitivity and inter observer agreement of 67ga imaging and 18f-fdg pet","volume":"55","author":"Keijsers","year":"2011","journal-title":"Q. J. Nucl. Med. Mol. Imaging"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00259-008-0770-9","article-title":"18f-fdg pet\/ct in sarcoidosis management: Review and report of 20 cases","volume":"35","author":"Braun","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MCP.0000000000000892","article-title":"The role of pet in the management of sarcoidosis","volume":"28","author":"Vender","year":"2022","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.rmed.2012.11.011","article-title":"Severity of pulmonary involvement and 18f-fdg pet activity in sarcoidosis","volume":"107","author":"Mostard","year":"2013","journal-title":"Respir. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/RLU.0b013e31827a27df","article-title":"18f-fdg pet\/ct for the assessment of disease extension and activity in patients with sarcoidosis: Results of a preliminary prospective study","volume":"38","author":"Ambrosini","year":"2013","journal-title":"Clin. Nucl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Chen, H., Jin, R., Wang, Y., Li, L., Li, K., and He, Y. (2018). The utility of 18f-fdg pet\/ct for monitoring response and predicting prognosis after glucocorticoids therapy for sarcoidosis. BioMed Res. Int., 2018.","DOI":"10.1155\/2018\/1823710"},{"key":"ref_66","first-page":"372","article-title":"Role of serial f-18 fdg pet\/ct scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis","volume":"33","author":"Maturu","year":"2016","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.chest.2020.04.074","article-title":"Mixed ventilatory defects in pulmonary sarcoidosis: Prevalence and clinical features","volume":"158","author":"Kouranos","year":"2020","journal-title":"Chest"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.202204-328OC","article-title":"Heterogeneity of lung function phenotypes in sarcoidosis: Role of race and sex differences","volume":"20","author":"Sharp","year":"2023","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.06-2822","article-title":"Six-minute walk test and health status assessment in sarcoidosis","volume":"132","author":"Baughman","year":"2007","journal-title":"Chest"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"106801","DOI":"10.1016\/j.rmed.2022.106801","article-title":"The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry","volume":"196","author":"Gupta","year":"2022","journal-title":"Respir. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of sarcoidosis","volume":"28","author":"Rosen","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_72","first-page":"474","article-title":"Serum angiotensin converting enzyme in the diagnosis of pulmonary sarcoidosis","volume":"38","author":"Mathur","year":"1990","journal-title":"J. Assoc. Physicians India"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"Ace and sil-2r correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"Vorselaars","year":"2015","journal-title":"Respir. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1515\/jomb-2016-0017","article-title":"Verifying sarcoidosis activity: Chitotriosidase versus ace in sarcoidosis\u2014A case-control study","volume":"35","author":"Popevic","year":"2016","journal-title":"J. Med. Biochem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e12205","DOI":"10.1097\/MD.0000000000012205","article-title":"Relationship between ct activity score with lung function and the serum angiotensin converting enzyme in pulmonary sarcoidosis on chest hrct","volume":"97","author":"Duan","year":"2018","journal-title":"Medicine"},{"key":"ref_76","first-page":"634","article-title":"Role of interleukin-2 release by lung t-cells in active pulmonary sarcoidosis","volume":"128","author":"Hunninghake","year":"1983","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_77","first-page":"49","article-title":"C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis","volume":"27","author":"Sweiss","year":"2010","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_78","first-page":"331","article-title":"Predictive value of c-reactive protein and clinically relevant baseline variables in sarcoidosis","volume":"33","author":"McDonnell","year":"2016","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"key":"ref_80","first-page":"e2022011","article-title":"Value of pulmonary function testing identifying progressive pulmonary disease in fibrotic sarcoidosis: Results of a prospective feasibility study","volume":"39","author":"Baughman","year":"2022","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_81","first-page":"S0012-3692(23)05666-0","article-title":"Hrct fibrotic patterns in stage 4 pulmonary sarcoidosis: Impact on pulmonary function and survival","volume":"23","author":"Obi","year":"2023","journal-title":"Chest"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00025212","article-title":"Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function","volume":"40","author":"Nunes","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","article-title":"Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","article-title":"Ers clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_85","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: Results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_87","first-page":"201","article-title":"A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis","volume":"23","author":"Rossman","year":"2006","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.rmed.2013.10.014","article-title":"Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients","volume":"107","author":"Baughman","year":"2013","journal-title":"Respir. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e00539","DOI":"10.1002\/rcr2.539","article-title":"Honeycomb lung-like structures resulting from clustering of traction bronchiectasis distally in sarcoidosis","volume":"8","author":"Sawahata","year":"2020","journal-title":"Respirol. Case Rep."},{"key":"ref_90","first-page":"154","article-title":"Clinical bronchiectasis complicating pulmonary sarcoidosis: Case series of seven patients","volume":"19","author":"Lewis","year":"2002","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAJ.0b013e3181b97635","article-title":"Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations","volume":"339","author":"McKinzie","year":"2010","journal-title":"Am. J. Med. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1378\/chest.12-1060","article-title":"Acute pulmonary exacerbations of sarcoidosis","volume":"142","author":"Panselinas","year":"2012","journal-title":"Chest"},{"key":"ref_93","first-page":"e2021035","article-title":"Roflumilast (daliresp(r)) to reduce acute pulmonary events in fibrotic sarcoidosis: A multi-center, double blind, placebo controlled, randomized clinical trial","volume":"38","author":"Baughman","year":"2021","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0761-8425(04)71582-X","article-title":"Opportunistic infections and sarcoidosis","volume":"21","author":"Girard","year":"2004","journal-title":"Rev. Mal. Respir."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1183\/13993003.00457-2016","article-title":"Sarcoidosis-related mortality in france: A multiple-cause-of-death analysis","volume":"48","author":"Jamilloux","year":"2016","journal-title":"Eur. Respir. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1602396","DOI":"10.1183\/13993003.02396-2016","article-title":"Chronic pulmonary aspergillosis complicating sarcoidosis","volume":"49","author":"Uzunhan","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/thx.38.8.579","article-title":"What happens to patients with pulmonary aspergilloma? Analysis of 23 cases","volume":"38","author":"Rafferty","year":"1983","journal-title":"Thorax"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1183\/09031936.05.00083404","article-title":"Pulmonary hypertension in advanced sarcoidosis: Epidemiology and clinical characteristics","volume":"25","author":"Shorr","year":"2005","journal-title":"Eur. Respir. J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0012-3692(15)37649-2","article-title":"Predicting mortality in patients with sarcoidosis awaiting lung transplantation","volume":"124","author":"Shorr","year":"2003","journal-title":"Chest"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (relief): A double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1513\/AnnalsATS.202102-146ST","article-title":"Defining modern pulmonary rehabilitation. An official american thoracic society workshop report","volume":"18","author":"Holland","year":"2021","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_103","first-page":"CD005305","article-title":"Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease","volume":"12","author":"Puhan","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_104","first-page":"CD003793","article-title":"Pulmonary rehabilitation for chronic obstructive pulmonary disease","volume":"2015","author":"McCarthy","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1378\/chest.70.5.606","article-title":"Hospitalization needs during an outpatient rehabilitation program for severe chronic airway obstruction","volume":"70","author":"Hudson","year":"1976","journal-title":"Chest"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/thx.2009.124164","article-title":"Outpatient pulmonary rehabilitation following acute exacerbations of copd","volume":"65","author":"Seymour","year":"2010","journal-title":"Thorax"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1513\/AnnalsATS.201512-836OC","article-title":"The unmet educational needs of patients with interstitial lung disease. Setting the stage for tailored pulmonary rehabilitation","volume":"13","author":"Morisset","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_108","first-page":"CD011285","article-title":"Exercise-based rehabilitation programmes for pulmonary hypertension","volume":"1","author":"Morris","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.healun.2013.04.002","article-title":"Pulmonary rehabilitation in lung transplant candidates","volume":"32","author":"Li","year":"2013","journal-title":"J. Heart Lung Transplant."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00408-015-9784-9","article-title":"Benefits of physical training in sarcoidosis","volume":"193","author":"Strookappe","year":"2015","journal-title":"Lung"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"107432","DOI":"10.1016\/j.rmed.2023.107432","article-title":"Pulmonary rehabilitation in sarcoidosis: A systematic review and meta-analysis","volume":"219","author":"Caballeria","year":"2023","journal-title":"Respir. Med."},{"key":"ref_112","first-page":"87","article-title":"Infection prevention in sarcoidosis: Proposal for vaccination and prophylactic therapy","volume":"37","author":"Syed","year":"2020","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1203475418811335","article-title":"Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies","volume":"23","author":"Papp","year":"2019","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1164\/rccm.202009-3608ST","article-title":"Home oxygen therapy for adults with chronic lung disease. An official american thoracic society clinical practice guideline","volume":"202","author":"Jacobs","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ajt.15279","article-title":"Optn\/srtr 2017 annual data report: Lung","volume":"2","author":"Valapour","year":"2019","journal-title":"Am. J. Transplant."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.healun.2015.08.014","article-title":"The registry of the international society for heart and lung transplantation: Thirty-second official adult lung and heart-lung transplantation report\u20142015; focus theme: Early graft failure","volume":"34","author":"Yusen","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014\u2014An update from the pulmonary transplantation council of the international society for heart and lung transplantation","volume":"34","author":"Weill","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Kim, J.S., and Gupta, R. (2023). Lung transplantation in pulmonary sarcoidosis. J. Autoimmun., 103135.","DOI":"10.1016\/j.jaut.2023.103135"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.healun.2016.01.010","article-title":"Effect of the lung allocation score on lung transplantation in the united states","volume":"35","author":"Egan","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"ref_120","first-page":"00738","article-title":"Sarcoidosis lung transplantation waitlist mortality, a national registry database study","volume":"9","author":"Gayen","year":"2023","journal-title":"ERJ Open Res"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.transproceed.2023.01.018","article-title":"Lung transplantation waitlist mortality among sarcoidosis patients by lung allocation score grouping","volume":"55","author":"Gayen","year":"2023","journal-title":"Transplant. Proc."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.rmed.2019.09.001","article-title":"Mortality for sarcoidosis patients on the transplant wait list in the lung allocation score era: Experience from a high volume center","volume":"157","author":"Gangemi","year":"2019","journal-title":"Respir. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2003358","DOI":"10.1183\/13993003.03358-2020","article-title":"Lung transplantation for sarcoidosis: Outcome and prognostic factors","volume":"58","author":"Valeyre","year":"2021","journal-title":"Eur. Respir. J."},{"key":"ref_124","first-page":"92","article-title":"Lung transplantation for pulmonary sarcoidosis","volume":"36","author":"Meyer","year":"2019","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1378\/chest.125.3.990","article-title":"Sarcoidosis, race, and short-term outcomes following lung transplantation","volume":"125","author":"Shorr","year":"2004","journal-title":"Chest"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/thoraxjnl-2015-207497","article-title":"Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA","volume":"71","author":"Taimeh","year":"2016","journal-title":"Thorax"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/1\/241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:45:06Z","timestamp":1760132706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/1\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":126,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["jcm13010241"],"URL":"https:\/\/doi.org\/10.3390\/jcm13010241","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,31]]}}}